Schrödinger, Inc. (SDGR)

Market Cap	1.62B
Revenue (ttm)	193.35M
Net Income (ttm)	-177.58M
Shares Out	72.86M
EPS (ttm)	-2.45
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	190,500
Open	22.13
Previous Close	22.48
Day's Range	21.98 - 22.47
52-Week Range	16.67 - 38.00
Beta	1.56
Analysts	Buy
Price Target	32.90 (+48.07%)
Earnings Date	Nov 12, 2024

About SDGR

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serv...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Feb 6, 2020
• Employees: 867
• Stock Exchange: NASDAQ
• Ticker Symbol: SDGR
• Website: https://www.schrodinger.com

Analyst Forecast

According to 10 analysts, the average rating for SDGR stock is "Buy." The 12-month stock price forecast is $32.9, which is an increase of 48.07% from the latest price.

Price Target

$32.9

(48.07% upside)

Analyst Consensus: Buy